CRIS Curis Inc

Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers.

$4.49  -0.28 (-5.87%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  91,609,165
Average volume:  2,110,500
Market cap:   $436,975,717
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    231269200
ISIN:        US2312692005
Sedol:      BDGGJ94
Valuation   (See tab for details)
PE ratio:   -10.46
PB ratio:   4.00
PS ratio:   41.47
Return on equity:   -38.22%
Net income %:   -373.25%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy